These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 8410683)

  • 21. Effect of protein binding on 4-methylumbelliferyl sulfate desulfation kinetics in perfused rat liver.
    Chiba M; Pang KS
    J Pharmacol Exp Ther; 1993 Aug; 266(2):492-9. PubMed ID: 8355186
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dose-dependent bioavailability and metabolism of salicylamide in dogs.
    Waschek JA; Rubin GM; Tozer TN; Fielding RM; Couet WR; Effeney DJ; Pond SM
    J Pharmacol Exp Ther; 1984 Jul; 230(1):89-93. PubMed ID: 6747835
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alteration of transit time and direction of flow to probe the heterogeneous distribution of conjugating activities for harmol in the perfused rat liver preparation.
    Dawson JR; Weitering JG; Mulder GJ; Stillwell RN; Pang KS
    J Pharmacol Exp Ther; 1985 Sep; 234(3):691-7. PubMed ID: 4032287
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Futile cycling between 4-methylumbelliferone and its conjugates in perfused rat liver.
    Ratna S; Chiba M; Bandyopadhyay L; Pang KS
    Hepatology; 1993 May; 17(5):838-53. PubMed ID: 8491453
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Extrapolation of the Hepatic Clearance of Drugs in the Absence of Albumin In Vitro to That in the Presence of Albumin In Vivo: Comparative Assessement of 2 Extrapolation Models Based on the Albumin-Mediated Hepatic Uptake Theory and Limitations and Mechanistic Insights.
    Poulin P; Haddad S
    J Pharm Sci; 2018 Jul; 107(7):1791-1797. PubMed ID: 29567347
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An integrated approach to model hepatic drug clearance.
    Liu L; Pang KS
    Eur J Pharm Sci; 2006 Nov; 29(3-4):215-30. PubMed ID: 16806855
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics of ketoprofen in rats: effect of age and dose.
    Satterwhite JH; Boudinot FD
    Biopharm Drug Dispos; 1992 Apr; 13(3):197-212. PubMed ID: 1576328
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Release of mutagenic metabolites of benzo[a]pyrene from the perfused rat liver after inhibition of glucuronidation and sulfation by salicylamide.
    Bock KW; Bock-Hennig BS; Lilienblum W; Volp RF
    Chem Biol Interact; 1981 Aug; 36(2):167-77. PubMed ID: 6268312
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Salicylamide sulfate cell entry in perfused rat liver: a multiple-indicator dilution study.
    Xu X; Schwab AJ; Barker F; Goresky CA; Pang KS
    Hepatology; 1994 Jan; 19(1):229-44. PubMed ID: 8276359
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Kinetics of sulfation in the rat in vivo and in the perfused rat liver.
    Mulder GJ
    Fed Proc; 1986 Jul; 45(8):2229-34. PubMed ID: 3087784
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Kinetic study of the hepatobiliary transport of a new prostaglandin receptor agonist.
    Imawaka H; Sugiyama Y
    J Pharmacol Exp Ther; 1998 Mar; 284(3):949-57. PubMed ID: 9495854
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Current models of hepatic pharmacokinetics: flow effects on kinetic constants of ethanol elimination in perfused rat liver.
    Keiding S; Priisholm K
    Biochem Pharmacol; 1984 Oct; 33(20):3209-12. PubMed ID: 6487367
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dose-dependent hepatic handling of l-propranolol determined by multiple indicator dilution method: influence of tissue binding of l-propranolol on its hepatic elimination.
    Miyauchi S; Sawada Y; Iga T; Hanano M; Sugiyama Y
    Biol Pharm Bull; 1993 Oct; 16(10):1019-24. PubMed ID: 8287031
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Some quantitative evaluation of first-pass metabolism of salicylamide in rabbit and rat.
    Shibasaki J; Konishi R; Koike M; Imamura A; Sueyasu M
    J Pharmacobiodyn; 1981 Feb; 4(2):91-100. PubMed ID: 7277202
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An enzyme-distributed system for lidocaine metabolism in the perfused rat liver preparation.
    Pang KS; Terrell JA; Nelson SD; Feuer KF; Clements MJ; Endrenyi L
    J Pharmacokinet Biopharm; 1986 Apr; 14(2):107-30. PubMed ID: 3746635
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Supplemental Analysis of the Prediction of Hepatic Clearance of Binary Mixtures of Bisphenol A and Naproxen Determined in an Isolated Perfused Rat Liver Model to Promote the Understanding of Potential Albumin-Facilitated Hepatic Uptake Mechanism.
    Poulin P; Bteich M; Haddad S
    J Pharm Sci; 2017 Nov; 106(11):3207-3214. PubMed ID: 28823401
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protein binding and hepatobiliary distribution of valproic acid and valproate glucuronide in rats.
    Brouwer KL; Hall ES; Pollack GM
    Biochem Pharmacol; 1993 Feb; 45(3):735-42. PubMed ID: 8442771
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical significance of pharmacokinetic models of hepatic elimination.
    Morgan DJ; Smallwood RA
    Clin Pharmacokinet; 1990 Jan; 18(1):61-76. PubMed ID: 2178850
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of a protein binding change on unbound and total plasma concentrations for drugs of intermediate hepatic extraction.
    Smallwood RH; Mihaly GW; Smallwood RA; Morgan DJ
    J Pharmacokinet Biopharm; 1988 Oct; 16(5):529-42. PubMed ID: 3199317
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of Nonlinear Pharmacokinetics of a Highly Albumin-Bound Compound: Contribution of Albumin-Mediated Hepatic Uptake Mechanism.
    Fukuchi Y; Toshimoto K; Mori T; Kakimoto K; Tobe Y; Sawada T; Asaumi R; Iwata T; Hashimoto Y; Nunoya KI; Imawaka H; Miyauchi S; Sugiyam Y
    J Pharm Sci; 2017 Sep; 106(9):2704-2714. PubMed ID: 28465151
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.